Why do i get rls at night

Overview

Restless Legs Syndrome (RLS), also known as Willis-Ekbom Disease, is a neurological sensorimotor disorder characterized by an irresistible urge to move the legs, often accompanied by uncomfortable sensations. First described in medical literature by English physician Thomas Willis in 1672, the condition gained modern recognition when Swedish neurologist Karl-Axel Ekbom published comprehensive studies in 1945. The International Restless Legs Syndrome Study Group established formal diagnostic criteria in 1995, which were later revised in 2003 and 2014. RLS affects approximately 7-10% of the U.S. population, with prevalence increasing with age and showing a slight female predominance. The condition exists in primary (idiopathic) and secondary forms, with secondary RLS often associated with iron deficiency, pregnancy, renal failure, or neurological conditions. RLS significantly impacts quality of life, with studies showing it contributes to sleep deprivation, daytime fatigue, and reduced productivity.

How It Works

The nocturnal worsening of RLS symptoms involves complex interactions between circadian rhythms, dopamine pathways, and iron metabolism. Dopamine, a neurotransmitter that regulates movement, follows a circadian pattern with levels naturally decreasing in the evening. Since RLS is associated with dopamine dysfunction in the basal ganglia, this evening dopamine dip may trigger symptoms. Simultaneously, iron levels exhibit diurnal variation, with serum iron concentrations typically lowest at night. Iron is essential for dopamine synthesis and receptor function, so nighttime iron reduction may exacerbate RLS. Additionally, the body's core temperature decreases during sleep preparation, which may affect nerve conduction. The combination of reduced physical activity in the evening, prolonged sitting or lying down, and fatigue from the day creates conditions where RLS sensations become more noticeable. Genetic factors also play a role, with specific gene variants (MEIS1, BTBD9, MAP2K5) identified in familial RLS cases.

Why It Matters

Understanding why RLS worsens at night is crucial for effective management and treatment. Nocturnal RLS significantly impacts sleep quality, with studies showing RLS patients average 5.5 hours of sleep per night compared to 7-8 hours in healthy individuals. This sleep disruption leads to daytime fatigue, impaired concentration, and reduced work productivity, costing an estimated $3.4 billion annually in lost productivity in the U.S. alone. Proper diagnosis and treatment can improve quality of life by 60-80% according to clinical studies. Recognizing the circadian pattern helps guide treatment timing, with medications like dopamine agonists typically administered 1-2 hours before symptom onset. Furthermore, understanding the iron-dopamine connection has led to iron supplementation as a first-line treatment for iron-deficient RLS patients, with studies showing improvement in 70% of cases when ferritin levels are below 75 μg/L.